For oncogene Kras in which its mutation occurs in early CRC, mice with both mutant KrasG12V/+ and Apc develop invasive intestinal carcinoma, while mice with mutant KrasG12V/+ alone need a much longer duration (>500 days) to develop carcinoma [62]. The gene discussed is KRAS; the disease is carcinoma.